dsbrady,From my miniscule understanding, I think you are on track. Isn't this what is referred to as a "poison pill?" When you say it would allow management to buy up remaining outstanding shares at half price, who is going to sell them their shares at half price? Wouldn't that half to be a secondary issue rather than outstanding shares?Tom
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra